Uric acid transport and disease.

By A. So, B. Thorens. Journal of Clinical Investigation, 2010

797 citations recorded by the source corpus.

Subfields: Epidemiology, Nephrology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/17fc4ad00e0f2433ef7454e7e6abbf4ec4f958bb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Steven Dooley
2. E. Ravussin
3. Mathieu Vinken

In Nephrology

1. Michael Doherty
2. E. Roddy

Citations in the corpus

• Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME (2013, positive): “In humans, GLUT9 is expressed only in the liver and kidney at high levels (Phay et al. 2000) and is transcribed into two alternatively spliced variants with different tissue distribution (So and Thorens 2010).”
• Gout. Epidemiology of gout (2010, background): “Recent interest has therefore particularly focused on genes regulating renal urate transport [36].”
• The NALP3/NLRP3 Inflammasome Instigates Obesity-Induced Autoinflammation and Insulin Resistance (2011, background): “Furthermore, visceral adiposity and obesity are associated with an increase in monosodium urate (MSU) levels and increased risk of diabetes and atherosclerosi”
• The SLC2 (GLUT) Family of Membrane Transporters (2013, neutral): “, 2001), urate (Bibert et al., 2009; Matsuo et al., 2008; So and Thorens, 2010), glucosamine (Maher and Harrison, 1990), and ascorbate (Lee et al.”